PRALATREXATE Drug Record
-
PRALATREXATE chembl:CHEMBL1201746 ApprovedAntineoplasticImmunotherapy
Alternate Names:
PDX PRALATREXATE FOLOTYN N-(4-(1-((2,4-DIAMINO-6-PTERIDINYL)METHYL)-3-BUTYNYL)BENZOYL)-L-GLUTAMIC ACID HSDB 7786 (2S)-2-((4-((1RS)-1-((2,4-DIAMINOPTERIDIN-6-YL)METHYL)BUT-3-YNYL)BENZOYL)AMINO)PENTANEDIOIC ACID PRALATREXATUM FOLOTYN® PRALATREXATO (2S)-2-({4-[1-(2,4-DIAMINOPTERIDIN-6-YL)PENT-4-YN-2-YL]BENZOYL}AMINO)PENTANEDIOIC ACID 10-PROPARGYL-10-DEAZAAMINOPTERIN pubchem.compound:148121 rxcui:662019 chembl:CHEMBL1201746 drugbank:06813 chemidplus:146464-95-1 Drug Info:
Year of Approval 2009 Drug Class antineoplastic agents FDA Approval not approved Drug Class Small molecule Drug Indications antineoplastic agent FDA Approval 2009 Drug Indications Antineoplastic Agents
-
Interaction Score: 20.61
Interaction Types & Directionality:
n/a Interaction Info:
-
Interaction Score: 6.87
Interaction Types & Directionality:
inhibitor (inhibitory) Interaction Info:
Trial Name PDX Novel drug target Established target Mechanism of Interaction Dihydrofolate reductase inhibitor -
Interaction Score: 2.94
-
- Version: 01-August-2011
Alternate Names:
PRALATREXATE Primary Drug Name Drug Info:
Drug Class antineoplastic agents Year of Approval 2009 Publications:
-
- Version: January-2014
Alternate Names:
Drug Info:
Drug Indications Antineoplastic Agents Drug Class small molecule FDA Approval 2009 Publications:
-
- Version: January-2014
Alternate Names:
Drug Info:
Drug Indications antineoplastic agent Drug Class Small molecule FDA Approval not approved Publications:
-
- Version: 2020.06.01
Alternate Names:
D02LWU TTD Drug ID Drug Info:
Publications:
-
- Version: chembl_23
Alternate Names:
Drug Info:
Publications:
-
- Version: ChEMBL_27
Alternate Names:
Drug Info:
Publications:
-
- Version: 15-June-2013
Alternate Names:
Drug Info:
Publications: